Literature DB >> 1943492

Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

Z Yasruel1, K Cianflone, A D Sniderman, M Rosenbloom, M Walsh, M A Rodriguez.   

Abstract

Acylation stimulating protein (ASP) is a 14 kDa plasma protein which causes in vitro triacylglycerol synthesis in human adipocytes and fibroblasts to increase substantially. ASP was found to stimulate human adipose tissue microsomal glycerophosphate acyltransferase and diacylglycerol acyltransferase activities by 23% and 90%, respectively. However, phosphatidate phosphohydrolase activity showed no increase in activity, nor did microsomal acyl-CoA synthetase activity. Moreover, ASP did not decrease the apparent Km of diacylglycerol acyltransferase (DGAT), but rather increased its apparent Vmax suggesting direct interaction of ASP with DGAT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943492     DOI: 10.1007/bf02536592

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  16 in total

1.  Stimulation of triacylglycerol synthesis by Z protein in rat liver and intestinal mucosa.

Authors:  P J O'Doherty; A Kuksis
Journal:  FEBS Lett       Date:  1975-12-15       Impact factor: 4.124

2.  Metabolic response of Acylation Stimulating Protein to an oral fat load.

Authors:  K Cianflone; H Vu; M Walsh; A Baldo; A Sniderman
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

3.  Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein.

Authors:  D A Burnett; N Lysenko; J A Manning; R K Ockner
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

4.  Stimulation of monoacylglycerophosphate formation by Z protein.

Authors:  S Mishkin; R Turcotte
Journal:  Biochem Biophys Res Commun       Date:  1974-09-09       Impact factor: 3.575

5.  The purification and properties of microsomal palmitoyl-coenzyme A synthetase.

Authors:  J Bar-Tana; G Rose; B Shapiro
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

6.  Purification and characterization of acylation stimulating protein.

Authors:  K M Cianflone; A D Sniderman; M J Walsh; H T Vu; J Gagnon; M A Rodriguez
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

7.  Purification of liver cytosolic proteins that stimulate triacylglycerol synthesis.

Authors:  D A Roncari; E Y Mack
Journal:  Can J Biochem       Date:  1981 Nov-Dec

8.  Glycerolipid biosynthesis in rat adipose tissue. I. Properties and distribution of glycerophosphate acyltransferase and effect of divalent cations on neutral lipid formation.

Authors:  S C Jamdar; H J Fallon
Journal:  J Lipid Res       Date:  1973-09       Impact factor: 5.922

9.  The effect of a plasma protein fraction on lipid synthesis in cultured skin fibroblasts from normals and patients with hyperapobetalipoproteinemia.

Authors:  K Cianflone; M A Rodriguez; M Walsh; H Vu; A D Sniderman
Journal:  Clin Invest Med       Date:  1988-04       Impact factor: 0.825

10.  The effect of ASP on the adipocyte of the morbidly obese.

Authors:  M J Walsh; A D Sniderman; K Cianflone; H Vu; M A Rodriguez; R A Forse
Journal:  J Surg Res       Date:  1989-05       Impact factor: 2.192

View more
  23 in total

Review 1.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

2.  Metabolic impact on serum levels of complement component 3 in Japanese patients.

Authors:  Isao Ohsawa; Hiroyuki Inoshita; Masaya Ishii; Gaku Kusaba; Nobuyuki Sato; Satoshi Mano; Kisara Onda; Tomohito Gohda; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 3.  Acylation-stimulating protein.

Authors:  K M Cianflone
Journal:  CMAJ       Date:  1992-05-15       Impact factor: 8.262

4.  Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein.

Authors:  Takayuki Fujita; Takayuki Fujioka; Tetsuo Murakami; Atsushi Satomura; Yoshinobu Fuke; Koichi Matsumoto
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 5.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

6.  Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.

Authors:  Sabina Paglialunga; Pierre Julien; Youssef Tahiri; Francois Cadelis; Jean Bergeron; Daniel Gaudet; Katherine Cianflone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

7.  The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.

Authors:  Sabina Paglialunga; Alexandre Fisette; Mercedes Munkonda; Ying Gao; Denis Richard; Katherine Cianflone
Journal:  BMC Physiol       Date:  2010-04-23

Review 8.  The role of the complement system in metabolic organs and metabolic diseases.

Authors:  Julia Phieler; Ruben Garcia-Martin; John D Lambris; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

9.  Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations.

Authors:  Honglei Jiang; Xiangju Liu; Dong Wang; Fang Guo; Jidong Liu; Xiaotang Liang; Zhaoqin Xing; Chunlin Cao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.

Authors:  Minoru Takahashi; Yumi Ishida; Daisuke Iwaki; Kazuko Kanno; Toshiyuki Suzuki; Yuichi Endo; Yoshimi Homma; Teizo Fujita
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.